Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value ($000): $193,229 (100.0% shares, 0.0% debt)

Holdings (16)

— Medivation, Inc. 75.9%

Value ($000) $146,733 Shares 2,279,519 Est. Cost $49.20 Unrealized —

— Ampio Pharmaceuticals Inc. 9.7%

Value ($000) $18,824 Shares 2,964,401 Est. Cost $6.37 Unrealized —

— Alcobra Ltd 6.5%

Value ($000) $12,469 Shares 687,000 Est. Cost $8.47 Unrealized —

— Synthetic Biologics Inc. 1.8%

Value ($000) $3,495 Shares 1,360,000 Est. Cost $1.51 Unrealized —

— Keryx Biopharmaceuticals Inc. 1.8%

Value ($000) $3,408 Shares 200,000 Est. Cost $10.21 Unrealized —

— Newlink Genetics Corp 1.1%

Value ($000) $2,199 Shares 77,437 Est. Cost $19.35 Unrealized —

NWBO Northwest Biotherapeutics Inc 0.8%

Value ($000) $1,450 Shares 200,300 Est. Cost $5.93 Unrealized 0.0%

— Inovio Pharmaceuticals Inc. 0.7%

Value ($000) $1,360 Shares 408,352 Est. Cost $2.86 Unrealized —

— Merrimack Pharmaceuticals Inc. 0.4%

Value ($000) $809 Shares 160,585 Est. Cost $5.18 Unrealized —

— Galmed Pharmaceuticals Ltd 0.4%

Value ($000) $746 Shares 65,000 Est. Cost $11.48 Unrealized —

— Advaxis Inc. 0.4%

Value ($000) $706 Shares 225,000 Est. Cost $4.21 Unrealized —

— Nephrogenex INc 0.2%

Value ($000) $412 Shares 50,000 Est. Cost $8.24 Unrealized —

— Parkervision Inc. 0.1%

Value ($000) $240 Shares 50,000 Est. Cost $4.55 Unrealized —

— Celsus Therapeutics Plc 0.1%

Value ($000) $151 Shares 23,255 Est. Cost $6.49 Unrealized —

— Advaxis Inc. 0.1%

Value ($000) $141 Shares 112,500 Est. Cost $1.65 Unrealized —

— Echo Therapeutics Inc. 0.0%

Value ($000) $86 Shares 28,630 Est. Cost $0.25 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	2,279,519	$146,733	75.9%	$49.20	—	Com	58501N101
—	Ampio Pharmaceuticals Inc.	2,964,401	$18,824	9.7%	$6.37	—	Com	03209T109
—	Alcobra Ltd	687,000	$12,469	6.5%	$8.47	—	SHS	M2239P109
—	Synthetic Biologics Inc.	1,360,000	$3,495	1.8%	$1.51	—	COM	87164U102
—	Keryx Biopharmaceuticals Inc.	200,000	$3,408	1.8%	$10.21	—	Com	492515101
—	Newlink Genetics Corp	77,437	$2,199	1.1%	$19.35	—	Com	651511107
NWBO	Northwest Biotherapeutics Inc	200,300	$1,450	0.8%	$5.93	0.0%	COM PAR $0.001	66737P600
—	Inovio Pharmaceuticals Inc.	408,352	$1,360	0.7%	$2.86	—	COM	45773H102
—	Merrimack Pharmaceuticals Inc.	160,585	$809	0.4%	$5.18	—	COM	590328100
—	Galmed Pharmaceuticals Ltd	65,000	$746	0.4%	$11.48	—	SHS	M47238106
—	Advaxis Inc.	225,000	$706	0.4%	$4.21	—	COM NEW	7624208
—	Nephrogenex INc	50,000	$412	0.2%	$8.24	—	COMM	640667101
—	Parkervision Inc.	50,000	$240	0.1%	$4.55	—	COM	701354102
—	Celsus Therapeutics Plc	23,255	$151	0.1%	$6.49	—	SPONSORED ADR NE	15119A202
—	Advaxis Inc.	112,500	$141	0.1%	$1.65	—	W EXP 07/15/201	7624117
—	Echo Therapeutics Inc.	28,630	$86	0.0%	$0.25	—	Com New	27876L206